Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Wegovy Starting Doses Restrictions Will Continue Through The Year

10 Aug 2023

• By Jessica Merrill

supply and demand — Supply for Wegovy will continue to be tight this year • Source: Shutterstock

Related Content

Lilly Expects Mounjaro To Benefit From Novo Nordisk Cardiovascular Trial

08 Aug 2023

SELECT: Novo Nordisk Comes Roaring Back

08 Aug 2023

Wegovy Demand Busts Through Novo Nordisk’s Expanded Capacity

04 May 2023

Novo Bets On ‘Chequered’ CB1r Approach In Diabetic Kidney Disease With Inversago Buy

10 Aug 2023

Related Companies

Novo Nordisk A/S

Additional Topics

Launches Supply Chain Business Strategies Metabolic Disorders BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.